Duodopa (ABT-SLV187) is a first line therapy for advanced Parkinson's disease patients with severe motor fluctuations, when conventional oral therapy is not effective.
Type of Molecule
Approved in US (Duopa), EU and Japan
|Potential Indication||Product Type||Phase (1, 2, 3, Submitted, Approved)|
|Parkinson's||New Indication||Phase Approved Approved|